{"id":"680b1294-081d-5779-a2da-5d9b07085a55","stable_key":"475ea55a-65e9-51c3-a539-738a6a8f683f:mangiferin-energy-ratio","predicate":"increases","statement":"Norathyriol increased the cellular AMP-to-ATP ratio in the tested HepG2 model.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"395ae85d-8a4b-52ab-b8ca-246d7f129b3a","mechanism_event_label":"The energy-sensing signal changed alongside AMPK activation.","subject":{"id":"d0f7f42a-ac45-5144-9ea5-a7586896cc6e","slug":"norathyriol","display_name":"Norathyriol","entity_type_key":"small_molecule"},"object":{"id":"e0e3f6ca-9a5e-5ff1-a57c-72360c7b38b1","slug":"human-hepg2-amp-atp-ratio","display_name":"AMP-to-ATP ratio in human HepG2 cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"395ae85d-8a4b-52ab-b8ca-246d7f129b3a","stable_key":"475ea55a-65e9-51c3-a539-738a6a8f683f:mangiferin-energy-ratio-event","event_type":"biochemical_relationship","label":"The energy-sensing signal changed alongside AMPK activation.","description":"Norathyriol increased the cellular AMP-to-ATP ratio in the tested HepG2 model.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"d47321ac-44bb-5a88-afdb-6435b57a91b9","slug":"amp","display_name":"AMP","entity_type_key":"small_molecule"},"role":"measured_metabolite","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"58b974f1-d389-5bf6-81cd-889c44442c42","slug":"atp","display_name":"ATP","entity_type_key":"small_molecule"},"role":"measured_metabolite","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"d0f7f42a-ac45-5144-9ea5-a7586896cc6e","slug":"norathyriol","display_name":"Norathyriol","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"e0e3f6ca-9a5e-5ff1-a57c-72360c7b38b1","slug":"human-hepg2-amp-atp-ratio","display_name":"AMP-to-ATP ratio in human HepG2 cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/mangiferin-research/29563875.fulltext.txt\", \"locator\": \"Primary full-text span; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1a48a1f92d67cd91638969bb1ec3cb9f18cb3cb4e29c7e5f2bacf627dda76415\", \"start_char\": 35775, \"end_char\": 36269, \"text_sha256\": \"9c428b34591bbbb1e453a4e5e2829b160930ef301d3b39065822f132f5a7dcd9\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"KK-Ay mouse liver experiments and mechanistic HepG2 studies","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Norathyriol in sodium-oleate lipid-loading model; micromolar range","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Phosphorylation and expression are scoped to experiments; no established human fatty-liver therapy or direct SIRT1 ligand claim.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Mangiferin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"mangiferin","display_name":"Mangiferin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Homo sapiens for HepG2 experiments; mouse findings separately scoped","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The energy-sensing signal changed alongside AMPK activation.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[mangiferin-p29563875] Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling. (2018). https://pubmed.ncbi.nlm.nih.gov/29563875/ DOI: 10.3389/fphar.2018.00201","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"HepG2 cells","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"6287aea2-6499-5bac-b082-98662263eb87","evidence_kind":"source_excerpt","locator":"Lines 471-482","start_line":471,"end_line":482,"excerpt":"### mangiferin-energy-ratio\nNorathyriol increased the cellular AMP-to-ATP ratio in the tested HepG2 model.\nCondition category: normal\nnutrient_topic: Mangiferin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The energy-sensing signal changed alongside AMPK activation.\norganism: Homo sapiens for HepG2 experiments; mouse findings separately scoped\ntissue_or_cell_type: HepG2 cells\nexperimental_model: KK-Ay mouse liver experiments and mechanistic HepG2 studies\nlimitations: Phosphorylation and expression are scoped to experiments; no established human fatty-liver therapy or direct SIRT1 ligand claim.\nexposure: Norathyriol in sodium-oleate lipid-loading model; micromolar range\nevidence_span: {\"source_cache\": \"artifacts/mangiferin-research/29563875.fulltext.txt\", \"locator\": \"Primary full-text span; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1a48a1f92d67cd91638969bb1ec3cb9f18cb3cb4e29c7e5f2bacf627dda76415\", \"start_char\": 35775, \"end_char\": 36269, \"text_sha256\": \"9c428b34591bbbb1e453a4e5e2829b160930ef301d3b39065822f132f5a7dcd9\"}\n[mangiferin-p29563875] Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling. (2018). https://pubmed.ncbi.nlm.nih.gov/29563875/ DOI: 10.3389/fphar.2018.00201","model_system":"KK-Ay mouse liver experiments and mechanistic HepG2 studies","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [mangiferin-p29563875] Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling. (2018). https://pubmed.ncbi.nlm.nih.gov/29563875/ DOI: 10.3389/fphar.2018.00201","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"267f942a-695a-5b62-a858-f71c06321ff5","stable_key":"import-475ea55a-65e9-51c3-a539-738a6a8f683f","title":"Mangiferin: metabolism, signaling and nutrient connections (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"295cb3a13742b3caeed19347ffcbc7863f5372d983da1625a942428919b4dc98","revision_id":"d9c2ee89-ff22-5e86-9d7f-7cb7e17f9ed2","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}